Work

Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study

Year: 2014

Type: article

Study design: Clinical Trial

Abstract: Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22 + B-acute lymphoblastic leukemia patients: a phase II study

Source: Haematologica

DOI: 10.3324/haematol.2014.120220

Authors: P. Chevallier, F. Huguet, E. Raffoux, A. Etienne, T. Leguay, F. Isnard, N. Robillard, T. Guillaume, J. Delaunay, A. Charbonnier, A. Pigneux, P. Peterlin, M. C. Bene, W. A. Wegener, D. M. Goldenberg, H. Dombret

Institutions: Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire de Toulouse, Hôpital Saint-Louis, Institut Paoli-Calmettes, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-Antoine, Immunomedics (United States)

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: Institut National Du Cancer, National Cancer Institute

Award: G669737343

OpenAlex ID: W2104952531

FWCI: 3.53

Cites: 16

Cited by: 25

Related to: 10